Merck KGaA to set up € 300 million Bioprocessing Production Center in South Korea
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
Subscribe To Our Newsletter & Stay Updated